Point72 Hong Kong LTD Vanda Pharmaceuticals Inc. Transaction History

Point72 Hong Kong LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$9.31 - $11.84 $6,442 - $8,193	692 Added 95.58%	1,416 $15,000
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $303 - $463	-28 Reduced 3.72%	724 $8,000
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $643 - $866	41 Added 5.77%	752 $12,000
Q3 2021 Nov 15, 2021	BUY	$15.35 - $21.27 $10,913 - $15,122	711 New	711 $12,000
Q3 2020 Nov 16, 2020	SELL	$9.32 - $12.02 $5,526 - $7,127	-593 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$9.66 - $12.02 $4,549 - $5,661	-471 Reduced 44.27%	593 $7,000
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $7,980 - $17,875	1,064 New	1,064 $11,000
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $711 - $915	-58 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$13.37 - $18.85 $12,380 - $17,455	-926 Reduced 94.11%	58 $1,000
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $17,308 - $30,553	984 New	984 $18,000
Q1 2018 May 15, 2018	SELL	$14.05 - $20.2 $1,686 - $2,424	-120 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.85 - $18.1 $783 - $1,104	61 Added 103.39%	120 $2,000
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $908 - $1,112	59	59 $1,000

156

44.7M

167K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $271M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.